Four months of rifampicin monotherapy for latent tuberculosis infection in children

Diagnosing and treating latent tuberculosis infection (LTBI) is an important part of efforts to combat tuberculosis (TB). The Korean guidelines for TB published in 2020 recommend 2 LTBI regimens for children and adolescents: 9 months of daily isoniazid (9H) and 3 months of daily isoniazid plus rifam...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Chi Eun, Menzies, Dick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Pediatric Society 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082252/
https://www.ncbi.nlm.nih.gov/pubmed/34727494
http://dx.doi.org/10.3345/cep.2021.01186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082252/
https://www.ncbi.nlm.nih.gov/pubmed/34727494
http://dx.doi.org/10.3345/cep.2021.01186

Ejemplares similares